Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Recurrence 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Hematologic Diseases 1HER2 Positive Breast Carcinoma 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

fludarabine phosphate 25Cyclophosphamide 25Busulfan 24Peripheral Blood Stem Cell Transplantation 20Tacrolimus 19Antilymphocyte Serum 19Methotrexate 16Radiotherapy 15Mycophenolic Acid 15Cyclosporine 14Methylprednisolone 12Filgrastim 11Whole-Body Irradiation 10Melphalan 10Etoposide 9Cord Blood Stem Cell Transplantation 9sargramostim 6Cytarabine 6Thalidomide 4Sirolimus 4Alemtuzumab 4thymoglobulin 3Thiotepa 3Granulocyte Colony-Stimulating Factor 3Carmustine 3Carboplatin 3ruxolitinib 2merphos 2gamma-Globulins 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Geriatric Assessment × Clear all
NCT04761770 2026-02-17

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
33 enrolled
MyeloidOther hematologic neoplasm

Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡